Skip to main content

Web Exclusives

FDA Approvals, Select Drug Profiles

Brintellix (Vortioxetine) Receives FDA Approval for the Treatment of Major Depressive Disorder

FDA Approvals, Select Drug Profiles

Injectafer (Ferric Carboxymaltose Injection) Receives FDA Approval for the Treatment of Iron-Deficiency Anemia

PharMerica and Onco360 Finalize Strategic Investment; Establish First National Oncology Pharmacy and Care Management Platform

FDA Approvals, Select Drug Profiles

Fetzima Extended-Release Receives FDA Approval for the Treatment of Major Depressive Disorder in Adults

FDA Approvals, Select Drug Profiles

Simponi Aria: A New Intravenous TNF Inhibitor for the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis

FDA Approvals, Select Drug Profiles

Breo Ellipta: A Fixed-Dose Combination Oral Inhaler Receives FDA Approval for Long-Term Maintenance Treatment of COPD

FDA Approvals, Select Drug Profiles

Invokana (Canagliflozin): First-in-Class SGLT2 Inhibitor Approved for the Treatment of Type 2 Diabetes

FDA Approvals, Select Drug Profiles

Nesina, Kazano, and Oseni: Three Alogliptin-Based Agents Approved for the Treatment of Type 2 Diabetes

FDA Approvals, Select Drug Profiles

Tafinlar and Mekinist: Two Oral Targeted Kinase Inhibitors for the Treatment of Patients with Metastatic Melanoma and BRAF Mutations

FDA Approvals, Select Drug Profiles

Simbrinza (Brinzolamide/Brimonidine Tartrate) Receives FDA Approval for the Treatment of Open-Angle Glaucoma or Ocular Hypertension

24
25
26
27
28
29
30

Page 27 of 37
Results 261 - 270 of 367